Pharmaceutical groups GSK and AstraZeneca are vying to be the first to finally upgrade their popular inhalers which deliver a life-saving puff of medicine but damage the planet.
Chiesi UK & Ireland and Hull University Teaching Hospitals NHS Trust have, today, announced initial findings from a collaborative working project highlighting that screening programmes provide a ...